C07K 14/64
Relaxins
C07K14/64 (Relaxins) appears on 106 US grants and 124 published applications in this corpus.
Search patents in C07K- Granted patents
- 106
- Published applications
- 124
- Assignees
- 60
- Inventors
- 243
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 3 |
| 2003 | 2 | 3 |
| 2004 | 2 | 1 |
| 2005 | 1 | 4 |
| 2006 | 2 | 3 |
| 2007 | 0 | 1 |
| 2008 | 1 | 3 |
| 2009 | 0 | 2 |
| 2010 | 1 | 4 |
| 2011 | 2 | 10 |
| 2012 | 2 | 4 |
| 2013 | 4 | 4 |
| 2014 | 3 | 8 |
| 2015 | 3 | 3 |
| 2016 | 4 | 6 |
| 2017 | 5 | 6 |
| 2018 | 2 | 6 |
| 2019 | 6 | 12 |
| 2020 | 6 | 6 |
| 2021 | 7 | 5 |
| 2022 | 6 | 10 |
| 2023 | 5 | 5 |
| 2024 | 3 | 5 |
| 2025 | 6 | 6 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Relaxin-2 fusion protein analogs and methods of using same30 Dec 2025US 12,509,497 B2Tectonic Operating Company, Inc.
- Peptides and combination of peptides for use in immunotherapy against cancers11 Nov 2025US 12,466,878 B2Immatics Biotechnologies GmbH
- Relaxin analogs and methods of using the same15 Jul 2025US 12,358,965 B2Eli Lilly and Company
- Relaxin immunoglobulin fusion proteins and methods of use15 Apr 2025US 12,275,771 B2The Scripps Research Institute
- Relaxin-2 fusion proteins1 Apr 2025US 12,264,188 B2Tectonic Operating Company, Inc.
- Pharmaceutical formulation comprising heterodimeric relaxin fusion proteins and uses thereof20 Aug 2026US 2026/0240953 A1AstraZeneca AB
- Relaxin-2 fusion protein analogs and methods of using same13 Aug 2026US 2026/0234213 A1Tectonic Operating Company, Inc.
- Relaxin analogs and methods of using the same7 May 2026US 2026/0125446 A1Eli Lilly and Company
- Peptides and combination of peptides for use in immunotherapy against cancers12 Feb 2026US 2026/0042828 A1Immatics Biotechnologies GmbH
- Relaxin-2 fusion protein analogs and methods of using same30 Oct 2025US 2025/0333467 A1Tectonic Operating Company, Inc.
Most cited
By later US patents
- Transient expression system for producing recombinant protein120US 5,024,939 AGenentech, Inc. · 1991
- Testis-specific insulin homolog polypeptides70US 5,959,075 AZymoGenetics, Inc. · 1999
- Use of relaxin in the treatment of bradycardia55US 5,478,807 AGenentech, Inc. · 1995
- Use of relaxin in cardiovascular therapy41US 5,166,191 AGenentech, Inc. · 1992
- Relaxin polypeptides comprising non-naturally encoded amino acids37US 8,735,539 B2Ambrx, Inc. · 2014